Secondary metabolites from the flower buds of Lonicera japonica and their in vitro anti-diabetic activities

Zhixiang Liu(Shenyang Pharmaceutical University), Shao‐Jiang Song(Shenyang Pharmaceutical University), Pinyi Gao(Shenyang University of Chemical Technology), Zhuo-Yang Cheng(Shenyang Pharmaceutical University), Lingzhi Li(Affiliated Hospital of Southwest Medical University), Qingbo Liu(Shenyang Pharmaceutical University), Qingjun He(Shenyang Pharmaceutical University), Bin Lin(Shenyang Pharmaceutical University)
Fitoterapia
February 24, 2016
10.1016/j.fitote.2016.02.011
Cited by 47

Related Papers

Understanding the gut–kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition
|Acta Diabetologica|2019|183
The Nuclear Receptor ESRRA Protects from Kidney Disease by Coupling Metabolism and Differentiation
|Cell Metabolism|2020|171
Gut microbiota–derived short-chain fatty acids and kidney diseases
|Drug Design Development and Therapy|2017|157
Isolation and characterization of Pseudomonas brassicacearum J12 as an antagonist against Ralstonia solanacearum and identification of its antimicrobial components
|Microbiological Research|2012|110
Inhibition of ACSS2-mediated histone crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence
|Nature Communications|2024|88